Player is loading...
Q&A - Sophia Genetics
Jurgi Camblong, CEO, Sophie Genetics
Thursday, Dec. 3, 2020 · 2:50 p.m. · 15m 41s
Embed
Transcriptions
Note: this content has been automatically generated.
00:00:00
and having maybe a thought oh question so you really in the middle i'm really
00:00:08
sure each each sedan it's really the patient health care that it was said that
00:00:14
treatment can slide you need all these different kinds decoders uh_huh
00:00:20
so i think in new model you need for us to have a a an angle which
00:00:25
is very very specific fights or indeed done uh you can tackle this problem from different angles
00:00:32
our understanding was that a patient data would become more and more digit allies
00:00:38
and that in the end real world data that would be put user in your speech else
00:00:43
would come will become eventually more important than the
00:00:46
data which uh produce enough academic research that upright
00:00:51
and so the i think they'll be too was really helping hospitals to
00:00:56
maximise the real world they thought they would be producing produced by themselves
00:01:01
so that we could create that movement so that we could help patients today
00:01:05
without patients to more or less well on the basis of this collective intelligence
00:01:09
he was that he had all thank you wanna you wanna ask questions please post them on sleeker that huh
00:01:18
ah actually i asked one time suggest are well it about about the proposal question
00:01:24
still fits you to put an animal wealthy council meeting we get a complex comfortable
00:01:32
so i'll i'll take advantage of p. l. c. cell
00:01:40
okay let's talk about the data difference they call their sins ah in
00:01:45
countries i wasn't very different in terms of finding the right targeting huh
00:01:50
problems that which countries has the point countries has their health care system looks very different an
00:01:56
how well how was it a little bit dead financial aspects regular customer had
00:02:01
very different but still it is to see that's very very good question uh
00:02:08
and i think uh before maybe addressing the specific of sophia taking a step back
00:02:14
i think that's a a challenge but an advantage as well for b. two b. tech companies in europe
00:02:21
so in other words uh in europe you you if you want to be
00:02:26
global right probably the first market after switzerland will be the rope and market
00:02:32
and so i think as you start addressing that market this oblige you
00:02:37
to view mall a model so in terms of pricing in terms of for corrections that will work
00:02:43
in this course still ashen off of countries so when it comes in the it's too soft
00:02:47
yeah even during the s. k. sector is going to be reimbursements games from the hospitals right
00:02:53
is going to be died that data privacy related issues is going to be as well at the beginning
00:02:59
how the budgets are being organised into the hospitals because now on the beginning when we started
00:03:05
there was no budget for the sass services software as a service uh a pattern right
00:03:12
and so on i think the best way to face was challenges
00:03:17
is just trying to go there to meet customers try to sell and
00:03:24
to some it you know to some extent this is what we make your company innovative as well
00:03:29
and i think the the the the good um stress that this puts into an organisation is that
00:03:36
unless you have a value proposes position that is very clear you
00:03:40
will not to be able to overcome these challenges right and so
00:03:44
in the case of soft yeah in the beginning but were furious
00:03:47
about data privacy were furious about okay we don't have the budget
00:03:51
but as soon as we would demonstrate them the accuracy
00:03:54
of the plot for this is when the streets would vanish
00:04:00
and i see going back a little more to contain we're sitting here
00:04:05
having all and you in finding your scripts do you could be an
00:04:11
in taking the couldn't look and sophie ha and how ah
00:04:15
depend any thank you and are you in some way or another
00:04:20
invalid tim to sell some problems yeah well no uh we never
00:04:25
thought we would be in infections is oh there's versus a company uh
00:04:30
me i work technologies can be used in the space but uh we
00:04:34
want it to be very folk used to make a difference into cancer and he narrated these orders
00:04:40
uh but when the time bin yeah a heated all of us we indeed decided as well to make some effort
00:04:46
and so the way with being able to l. y. as a
00:04:49
civilian how the genome of the buyers label right uh because uh
00:04:55
uh as of our samples and the choirs knew me passions maybe the new
00:04:58
strain speak on a more um c. v. or a than the previous ones
00:05:04
and um i think you know we are which could be huge so all in the end to
00:05:08
this year we're going to hell in a the analysis of a fifteen thousand sequences of the virus
00:05:15
um most of the time um uh it's one
00:05:18
percent of the positive cases that are being tested to
00:05:22
see how the very simple so this gives you a
00:05:24
magnitude of how ourself we're contributing to the civilians off
00:05:29
of the cars but unfortunately to be honest if our platform would be used at full capacity
00:05:35
a given weariness because that all of them have i can produce a genome of the of the virus
00:05:41
we could be able to tell you real time you know where are the
00:05:44
new by receipts and which one are more aggressive and how in terms of
00:05:51
time will rise and and regional rise in they are they're holding right
00:05:55
but uh you see despite not being anymore small company but
00:06:00
need neither of air established company we have the the you
00:06:03
haven't been able to convince up for example you europe and
00:06:06
commit community uh to uh be on board eating too that potential
00:06:12
so i'm really swedish tag accent beach cats instead
00:06:18
urgently need your your services now with their the tension that they're afraid of okay it's pleasure
00:06:26
by means before i can see how does the related sitting and thinking yeah i wanted to ask
00:06:31
so let somebody asked me time to find the market affecting having further i start
00:06:36
finding the right balance between question too much in spending too much on the candy uh_huh
00:06:42
i think uh the m. v. p. helps you to find the right product marketed right
00:06:47
uh so and and it's something you should continuously maintain a at least a
00:06:55
when uh your building a product offering that as a potential quibble
00:07:00
i don't know whether this applies to any uh product offering but in our case that's
00:07:04
the beauty of four platform right keep it can involve continuously and bring a new solutions continuously
00:07:10
so i would say maybe the the first m. v. p. is validated when
00:07:14
you sign your first contract right but until you haven't signed the first contract
00:07:18
it means you haven't been able to find any product marketed uh and then
00:07:22
you need to repeat that but it never ends um what they think is that
00:07:28
often in in europe uh companies don't invest enough in sales and marketing
00:07:35
um and i think at the very beginning
00:07:37
of a company whenever you start signing new contracts
00:07:42
you urgently needs to recruit a more sales people because they will be the one
00:07:47
again facing new customers and enabling you wither feedbacks to improve the
00:07:51
product so that you product can be even more broadly adopted so
00:07:56
i hope this answer the question i enjoyed it
00:08:00
there's always a balancing test m. r. k. for their credit with the n. p. s. involves
00:08:05
so it's it's circular as an iteration more than my one industry ha completely it's
00:08:10
completely circular and making you need to balance well your budget to give you a feel
00:08:15
uh i know we are in a regulated space somersault fight song wearing diagnostic tools and solutions
00:08:21
uh despite that uh our fourth recruit uh was
00:08:26
uh our v. p. says at the time so all
00:08:29
i was the first one then we have the worst y'all then we
00:08:32
other chief information officer we started to build the product but two thousand twelve
00:08:37
but but two thousand twelve i already recruited a v. p. says i i actually remember the time the
00:08:42
work telling me you have to be the one selling i was doing that but they wanted someone else
00:08:47
uh because otherwise you mean there's so much into
00:08:51
the uh uh the the r. n. d. f. words
00:08:54
without knowing what other constraints we we the out making sure that
00:08:59
the customers you pitching really well understand the value proposition you're offering
00:09:05
let's call it a ration eternity exactly and you know i have some
00:09:10
uh examples in mind of companies working give looking for example medical devices
00:09:16
and what i think would invest far too much into our before releasing i don't know that in some
00:09:21
countries unless the answer is being given by you're devising
00:09:25
ten minutes time be doctors will never adopt that right
00:09:29
so then this tells you that you need between invest in state rather than on content and that's why
00:09:35
continuously and being exposed to the market through the n. d. p. is so important
00:09:41
so i'm not from the perspective of it it keeps
00:09:45
him from that old engineers that are in the news today
00:09:49
i let her research background and then they found something anyone line should business
00:09:54
but you see i mean these differences from the academic world today
00:09:58
started world and what advice would you give to descend years yeah
00:10:03
i think uh uh there are differences but there are a
00:10:07
lot of common that commonalities as well uh same is start with
00:10:10
difference you taking the difference is that uh uh probably you
00:10:15
you can't fail more often then in the pure academic a sector
00:10:21
uh and you need to fade so you need to have this uh feedback loops of being very very quick
00:10:28
uh and you need to be able to change to private very quickly so myself a prior being uh
00:10:34
an entrepreneur a being an academic as well right and i was doing a research and work your biology
00:10:39
and uh i i i think for example during appears need maybe more difficult to pipe out
00:10:45
uh because uh you know that in the end you need to pass a at a fast
00:10:49
um well as an entrepreneur a thing you don't have to is it page to private very quickly
00:10:55
and you don't have to i would say as well i'm
00:10:58
becoming a lot with your product because maybe the idea is right
00:11:02
maybe the direction is right but maybe this is not the product that
00:11:05
will enable you to go there and so beta releasing that early than late
00:11:10
aside debating between uh academic research ending an entrepreneur that many things that are similar
00:11:17
as an academic research when you're right right you need to publish before the others actually could the pubic ashen
00:11:23
it's the cells it's signing the contract right it's a validating the value of your work
00:11:30
um in that race you need to know what the other academic centres
00:11:35
are doing what are the technologies thing around hand with who they are working
00:11:40
and this applies then to you as well as a researcher okay if
00:11:43
i know that my uh opponents or my competition as this a strand
00:11:48
what might be my different shatter how can i do things different from them
00:11:54
who are the people with whom i can partner it's got so that i can accelerate my research
00:11:59
it's all these principles really apply to the word of entrepreneurs as well
00:12:03
that's great news that means that if you had been is successful in
00:12:07
academics you don't tend to be scared to going to interconnect shape that
00:12:11
your your skills in your strain can still be
00:12:14
used in then you setting fully agree i think uh
00:12:17
especially the one that may have don't the p. h. d. at being extremely well trained uh for that
00:12:24
and same when it comes to the resilience right because uh when you do please do you
00:12:27
have to be extremely resilient and there's an entrepreneur you have to be extremely resilient as well
00:12:33
well that well some commonly asked questions and now first round of financing
00:12:39
um how was that mike where where did you find it and also
00:12:42
adelaide see that is and how this is a consistent help you but
00:12:47
resources strong how chairs network was helpful to yeah and the beginning and it's
00:12:52
so the the ecosystem of the seats and if you park at being a very useful
00:12:57
uh and this is why uh we uh incorporated the company here
00:13:01
actually we wanted to be you know environment that would be visible
00:13:06
uh and uh that um were people without the similar experiences right and so this
00:13:12
unable or satan or to get our lawyer to get our first to come down
00:13:16
uh this word basis from a right or one and l. c. d. panel for example
00:13:22
being challenged by themself as well when it comes to the first presentation
00:13:26
sure making about your business them so i think this were very very valuable
00:13:31
uh challenges that we got and enable us to
00:13:34
strand and to polish our story another clan definitively um
00:13:39
and what was your other questions just maybe ah yeah
00:13:42
the finance yeah so first financing you know i think uh
00:13:47
yeah uh well yesterday was talking to an entrepreneur and uh i was telling and i don't know if
00:13:52
they're investors here that i was telling him that make the investors feel privileged to invest in your company
00:14:00
and not the opposite i actually they should feel that
00:14:04
their religion investing your company and maybe as you start
00:14:09
uh shoot as well so all make the term shift yourself don't expect investors
00:14:16
to come with the term should make the term she'd go with term sheet
00:14:20
you have to try to make it look like you already have investors with you
00:14:26
no one they may be a median investor i don't know but what i can tell you that investors are ships
00:14:32
and so when you get one and the second one you can get as many as you want afterwards
00:14:38
okay so i think in these early stages of funding don't hesitate to talk to anyone and that's
00:14:45
that's i think it in advice they could assured don't hesitate to speak to investors enter your ideas
00:14:51
investors will challenge you but as a challenge you they
00:14:55
will help you to but perfect as were you value proposition
00:14:59
and you know if you write if you think that you will win
00:15:02
because you radius summer values and you don't want to share it with anyone
00:15:06
i can tell you will never with grey the holiday or nagging at at ling happy collaborating oreo
00:15:14
great i think that's time on our hands answer thinking very matcher advantage in in yeah uh_huh
00:15:21
and for those of you listening but i didn't start sketching and everybody
00:15:24
else these are great words of advise families they're very successful company in
00:15:29
uh in the in the space that we're here today sell anchorage it's
00:15:33
you ah and all that right now thank you very much for you
Conference Program
Welcome from the Sponsors
La Forge - InnoPeaks - Hewlett Packard - Pulse Incubateur HES - Geneus
Dec. 3, 2020 · 2:10 p.m.
Keynote - Sophia Genetics
Jurgi Camblong, CEO, Sophie Genetics
Dec. 3, 2020 · 2:20 p.m.
139 views
Q&A - Sophia Genetics
Jurgi Camblong, CEO, Sophie Genetics
Dec. 3, 2020 · 2:50 p.m.
115 views
